COPD and endocrine and metabolic alterations;EPOC y alteraciones endocrinometabólicas

Archivos de Bronconeumologia

Volumn 45, Issue SUPPL.5, 2009, Pages 42-46

  Martín, María Jesús Chillón ^a   Díez, Javier de Miguel ^a   Moreno, Alicia Ferreira ^a   Muñoz, Gema Sánchez ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Diabetes mellitus; Dyslipidemia; Endocrine and metabolic alterations; Malnutrition; Metabolic syndrome; Osteoporosis

Indexed keywords

GLUCOCORTICOID;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; ENDOCRINE DISEASE; EXERCISE; HUMAN; MALNUTRITION; METABOLIC DISORDER; METABOLIC SYNDROME X; OSTEOPOROSIS; PROGNOSIS; PULMONARY REHABILITATION; RISK FACTOR; SMOKING;

DIABETES MELLITUS; ENDOCRINE SYSTEM DISEASES; HUMANS; METABOLIC DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 72049124018     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(09)72863-7     Document Type: Article

References (47)

1. Horton R. The neglected epidemic of chronic disease. Lancet 366 (2005) 1514
2. Sobradillo V., Miravitlles M., Jiménez C.A., Gabriel R., Viejo J.L., Masa J.F., et al. Estudio IBERCOP en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo. Arch Bronconeumol 35 (1999) 159-166
3. Chatila W.M., Thomashow B.M., Minai O.A., Criner G.J., and Make B.J. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5 (2008) 549-555
4. De Miguel Díez J., and Méndez Bailón M. Comorbilidad en la EPOC. Impliocaciones diagnósticas y terapéuticas. Revista de Patología Respiratoria 11 Supl 2 (2008) 109-116
5. Sin D.D., Anthonisen N.R., Soriano J.B., and Agusti A.G. Mortality in COPD: Role of comorbidities. Eur Respir J 28 (2006) 1245-1257
6. Fabbri L.M., and Ferrari R. Chronic disease in the elderly: back to the future of internal medicine. Breathe 3 (2006) 40-49
7. Sánchez-Lora F.G., Amorós Martínez F., García Ordóñez M.A., and Custardoy Olavarrieta J. EPOC y trastornos endocrinometabólicos. Rev Clin Esp 207 Supl 1 (2007) 33-39
8. Barker D.J., Godfrey K.M., Fall C., Osmond C., Winter P.D., and Shaheen S.O. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 303 (1991) 671-675
9. Lithell H.O., McKeigue P.M., Berglund L., Mohsen R., Lithell U.B., and Leon D.A. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 312 (1996) 406-410
10. Sevenoaks M.J., and Stockley R.A. Chronic obstructive pulmonary disease, inflammation and co-morbidity - a common inflammatory phenotype?. Respir Res 7 (2006) 70
11. Fabbri L.M., Luppi F., Beghé B., and Rabe K.F. Complex chronic comorbidities of COPD. Eur Respir J 31 (2008) 204-212
12. Carrasco Garrido P., De Miguel Díez J., Rejas Gutiérrez J., Martín Centeno A., Gobartt Vázquez E., Gil de Miguel A., et al. Negative impacto f chronic obstructive pulmonary disease on the Elath-related quality of life of patients. Results of the EPIDEPOC study. Health and Quality of Life Outcomes 4 (2006) 31
13. Loukides S., and Polyzogopoulos D. The effect of diabetes mellitus on the outcome of patients with chronic obstructive pulmonary disease exacerbated due to respiratory infections. Respiration 63 (1996) 170-173
14. Will J.C., Galuska D.A., Ford E.S., Mokdad A., and Calle E.E. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohorte study. Int J Epidemiol 30 (2001) 540-546
15. Creutzberg E.C., and Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J 22 Suppl 46 (2004) 76S-80S
16. Poulain M., Doucet M., Major G.C., Drapeau V., Sériès F., Boulet L.P., et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ 174 (2006) 1293-1299
17. Engstrom G., and Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diab Med 19 (2002) 167-170
18. Rana J.S., Mittleman M.A., Sheihh J., Hu F.B., Manson J.E., Colditz G.A., et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 27 (2004) 2478-2484
19. Takabatake N., Nakamura H., Abe S., Inoue S., Hino T., Saito H., et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 1179-1184
20. Brooks G.A., Butterfield G.E., Wolfe R.R., Groves B.M., Mazzeo R.S., Sutton J.R., et al. Increased dependence on blood glucose after acclimatization to 4,300 m. J Appl Physiol 70 (1991) 919-927
21. Azevedo Jr. J.L., Carey J.O., Pories W.J., Morris P.G., and Dohm G.L. Hypoxia stimulates glucosa transport in insulin-resistent human skeletal muscle. Diabetes 44 (1995) 695-698
22. Hjalmarsen A., Aasebo U., Birkeland K., Sager G., and Jorde R. Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diabetes Metab (Paris) 22 (1996) 37-42
23. Funk G.C., Doberer D., Petrov V., and Block L.H. Hyperglycemia, bronchial artery sclerosis, and lung function. Am J Respir Crit Care Med 169 (2004) 3
24. Baker E.H., Janaway C.H., Philips B.J., Brennan A.L., Baines D.L., Wood D.M., et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 61 (2006) 284-289
25. Gudmundsson G., Gislason T., Lindberg E., Hallin R., Ulrik C.S., Brondum E., et al. Mortality in COPD patients discharged from hospital: the role of treatment ando comorbidity. Respir Res 7 (2006) 109
26. Blackburn D., Hux J., and Mamdani M. Quantification of the risk of the corticosteroidinduced diabetes mellitus among the elderly. J Gen Intern Med 17 (2002) 717-720
27. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
28. Ascaso J.F., González-Santos P., Hernández Mijares A., Mangas Rojas A., Massana Marín L., Millán Núñez-Cortés J., et al. Foro-HDL. Diagnóstico de síndrome metabólico. Adecuación de los criterios diagnósticos en nuestro medio. Clin Invest Arterioscl 18 (2006) 244-260
29. Hu G., Qiao Q., Toumilehto J., Balkau B., Borch-Johnsen K., Pyorala K., and DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
30. Marquis K., Maltais F., Duguay V., Bezeau A.M., LeBlanc P., Jobin J., et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehab 25 (2005) 226-232
31. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
32. Entrenas Costa L.M., and Fernández de Córdoba y Gamero J. Comorbilidad en la EPOC. EPOC. Inflamación, efectos sistémicos y comorbilidad (2008), Ergon, Madrid p, 81-113
33. Jorgensen N.R., Schwarz P., Holme I., Henriksen B.M., Petersen L.J., and Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease-A cross sectional study. Respir Med 101 (2007) 177-185
34. Van Staa T.P., Leufkens H.G., and Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int 13 (2002) 777-787
35. Gluck O., and Colice G. Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. Chest 125 (2004) 1859-1876
36. Reid M.B., and Li Y.P. Tumor necrosis factor-α and muscle wasting: a cellular perspective. Respir Res 2 (2001) 269-272
37. Chambers T.J. Regulation of the differentiation and function of osteoclasts. J Pathol 192 (2000) 4-13
38. Celli B.R., Cole C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
39. Soler J.J., Sánchez L., Román P., Martínez M.A., and Perpiñá M. Prevalencia de la desnutrición en pacientes ambulatorios con enfermedad pulmonar obstructiva estable. Arch Bronconeumol 40 (2004) 250-258
40. Marquis K., Debigaré R., Lacasse Y., Leblanc P., Jobin J., Carrier G., et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 809-813
41. Broelkhuizen R., Grimble R.F., Howell W.M., Shale D.J., Creutzberg E.C., Wouters E.F., et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1-β-511 single nucleotide polymorphism. Am J Clin Nutr 82 (2005) 1059-1064
42. Barreiro E., De la Puente B., Minguella J., Corominas J.M., Serrano S., Hussain S.N., et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 1116-1124
43. Arora N.S., and Rochester D.F. Respiratory muscle strength and maximal voluntary ventilation in undernourished patients. Am Rev Respir Dis 126 (1982) 5-8
44. Villablanca A.C., McDonald J.M., and Rutledge J.C. Smoking and cardiovascular disease. Clin Chest Med 21 (2000) 159-172
45. Laghi F., Antonescu-Turcu A., Collins E., Segal J., Tobin D.E., Jubran A., et al. Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life. Am J Respir Crit Care Med 171 (2005) 728-733
46. Walters J.A., Walters E.H., and Wood-Baker R. Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 3 (2005) CD005374
47. Pauwels R.A., Lofdahl C.G., Laitinen L.A., Schouten J.P., Postma D.S., Pride N.B., et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 340 (1999) 1948-1953